The role of randomized controlled trials, registries, observational databases in evaluating new interventions

Area of Science:

• * Medical research methodology
• * Clinical trial design
• * Evidence-based medicine

Background:

• * Randomized controlled trials (RCTs) are the gold standard for evaluating intervention safety and efficacy.
• * RCT data can be unavailable due to uncommon diseases/interventions, structural limitations, or practical/ethical barriers to randomization.
• * Medical reversals occur when interventions believed effective are later found ineffective or harmful in RCTs.

Purpose of the Study:

• * To explore the utility of registries and observational databases (ODBs) as alternatives to RCTs.
• * To address limitations of RCTs in specific clinical scenarios.
• * To compare the findings from ODBs with those from RCTs.

Main Methods:

• * Analysis of data from randomized controlled trials (RCTs).
• * Examination of data from high-quality registries and observational databases (ODBs).
• * Consideration of meta-analyses combining data from RCTs, registries, and ODBs.

Main Results:

• * ODBs can provide valuable data when RCT data is unavailable, featuring large, diverse patient populations.
• * While ODBs have limitations like potential biases and confounding covariates, analyses from high-quality ODBs often align with RCT conclusions.
• * Combining data from RCTs, registries, and ODBs through meta-analyses is sometimes appropriate.

Conclusions:

• * Registries and ODBs are crucial resources for comparing intervention efficacy, particularly when RCTs are not feasible.
• * Increased utilization of registries and ODBs can enhance the evidence base for clinical decision-making.
• * High-quality ODBs can yield clinically relevant results comparable to RCTs.